Compare ATNI & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATNI | CGC |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Pharmaceuticals and Biotechnology |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.7M | 401.0M |
| IPO Year | 1994 | 2023 |
| Metric | ATNI | CGC |
|---|---|---|
| Price | $32.60 | $0.96 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 67.9K | ★ 2.1M |
| Earning Date | 05-06-2026 | 05-29-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | 34.29 | ★ 84.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $727,975,000.00 | $12,759,000.00 |
| Revenue This Year | $3.12 | $8.27 |
| Revenue Next Year | $1.10 | $15.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.86 | $0.84 |
| 52 Week High | $32.28 | $2.38 |
| Indicator | ATNI | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 76.11 | 58.99 |
| Support Level | $25.03 | $0.98 |
| Resistance Level | N/A | $1.08 |
| Average True Range (ATR) | 1.06 | 0.04 |
| MACD | 1.06 | 0.01 |
| Stochastic Oscillator | 96.66 | 78.32 |
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.